美股A股
StockGist
Back
8-K2026-04-17· grok-4-1-fast-non-reasoning

EMMA · Emmaus Life Sciences, Inc.

0001213900-26-045250

SEC filing

Summary

Emmaus Life Sciences appointed Henry H. Du to its Board of Directors on April 16, 2026, filling the vacancy from Jon Kuwahara's resignation and expected to serve as sole Audit Committee member.

Key takeaways

Full analysis

The appointment of Henry H. Du to the Board addresses a recent vacancy from Jon Kuwahara's resignation, maintaining board continuity. Du's finance and accounting expertise, including his current role as VP Finance Accounting and interim CFO at Alpha Cognition—a biopharmaceutical firm—positions him well for the Audit Committee role. As a CPA with a BA from Claremont McKenna College and prior senior positions in life sciences, he brings relevant oversight capabilities. The lack of family ties or related transactions underscores a straightforward governance change with no immediate conflicts.